Background And Aim: Self-expandable metal stent (SEMS) is a favorable therapeutic option for patients with incurable malignant colonic obstruction (MCO). However, their long-term efficacy and safety compared with those of stoma creation have not been well investigated. This study aimed to compare these long-term outcomes between these two techniques in patients with incurable MCO.

Methods: This retrospective cohort included patients with incurable MCO with SEMS insertion ( = 105) and stoma creation ( = 97) between January 2009 and December 2019. The primary outcomes were patency after the procedure and 1-year re-intervention rates.

Results: The patency of the SEMS group was lower than that of the stoma group (88.9 93.2% at 6 months, 84.1 90.5% at 12 months, and 65.8 90.5% at 18 months; log-rank test,  = 0.024), but 1-year re-intervention rates were not different between the groups (10 8%,  = 0.558). The median patency durations were 190 days for SEMS insertion and 231 days for stoma creation. Majority (84%) of SEMS patients did not require any re-intervention until death. The early complication rate did not differ between the groups ( = 0.377), but SEMS insertion had fewer late minor complications than stoma creation (5 22%,  = 0.001).

Conclusion: SEMS insertion is a safe and effective treatment for patients with incurable MCO. Although SEMS insertion had a lower patency than stoma creation, especially after 1 year, the 1-year re-intervention rates were not different, and SEMS durability was sufficient in most patients.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9446394PMC
http://dx.doi.org/10.1002/jgh3.12800DOI Listing

Publication Analysis

Top Keywords

stoma creation
24
sems insertion
20
patients incurable
16
1-year re-intervention
12
sems
9
incurable malignant
8
malignant colonic
8
colonic obstruction
8
incurable mco
8
mco sems
8

Similar Publications

Aims: To map interventions in the sexuality of men with stomas.

Design: Scoping review, following JBI and PRISMA-ScR guidelines to report results.

Methods: Databases consulted were PubMed, via National Library of Medicine, Latin American and Caribbean Health Sciences Literature, Web of Science, Scopus, Embase, Scientific Electronic Library Online, Brazilian Electronic Library of Thesis and Dissertations, CAPES Catalogue of Thesis and Dissertations and Open Access Scientific Repository of Portugal.

View Article and Find Full Text PDF

Aim: Crohn's disease (CD) is regarded as a wasting disease, yet there is a growing population of CD patients with a body mass index (BMI) of 35 and above. The rate of postoperative complications is relatively high in CD patients but might be even higher in CD with morbid obesity (MO).

Methods: This was a retrospective study using a prospectively maintained database of all patients undergoing Ileocolic resection for CD between 2014 and 2021 in two referral centres, comparing postoperative complication rates according to BMI.

View Article and Find Full Text PDF

Stent stoma: Endoscopic stent insertion for refractory small intestine fistulas.

Scand J Surg

January 2025

Interdisciplinary Endoscopy Centre, Heidelberg University Hospital, Im Neuenheimer Feld 410, 69120 Heidelberg, Germany.

Background And Aims: The therapeutic management of fistulas presents significant challenges, often involving both conservative and surgical approaches. Despite these interventions, recurrence and postoperative mortality rates remain high. Endoscopic stent insertion into the fistula, along with the creation of a stent stoma, may offer a promising alternative for patients who fail surgical or conservative therapies.

View Article and Find Full Text PDF

Impact of biologics on stoma creation and reversal in Crohn's disease: a retrospective analysis from 2007 to 2021.

Tech Coloproctol

January 2025

Department of General Surgery, Jinling Hospital, Nanjing Medical University, No. 305 East Zhongshan Rd, Nanjing, 210002, People's Republic of China.

Background: Trends of stoma creation at index surgery for Crohn's disease (CD) in the biologics era has not been thoroughly investigated. This study aimed to assess the impact of increasing biologics use on stoma rates at index surgery of CD, as well as identifying risk factors for the creation and nonreversal of CD-related stoma.

Methods: In this single-center retrospective analysis, consecutive CD patients who underwent index bowel surgery from 2007 to 2021 were reviewed.

View Article and Find Full Text PDF

An a (AEF) is a rare but life-threatening condition where an abnormal connection forms between the aorta and the gastrointestinal tract, most commonly the duodenum. It can be primary (arising spontaneously due to an aortic aneurysm or infection) or secondary (complicating prior vascular surgery). Immediate recognition and surgical intervention are critical to manage severe gastrointestinal bleeding and prevent fatal outcomes.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!